Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-operative 5-aminolevulinic acid dose-finding study in CABG surgery
2020-001135-27Phase 2Unknown
- Sponsor
- University of Oxford
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of 5-aminolevulinic acid and sodium ferrous citrate in coronary arteriosclerosis, sponsored by University of Oxford. Primary endpoint: Change in HMOX1 mRNA expression. Status: unknown.
02
Drugs
5-aminolevulinic acidsodium ferrous citrate
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2020-001135-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001135-27.